SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-020756
Filing Date
2022-06-02
Accepted
2022-06-02 18:49:22
Documents
2
Period of Report
2022-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1619
2 EX-24 DOCUMENT attachment1.htm EX-24 4316
  Complete submission text file 0000899243-22-020756.txt   7311
Mailing Address C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON MA 02421
Business Address
Reed Joshua (Reporting) CIK: 0001746541 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40657 | Film No.: 22992440

Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)